Germany · Question · Kleine Anfrage
14/2760
Consequences for the Federal Republic of Germany from the death following gene therapy in the USA and evaluation of the German gene therapy studies (G-SIG: 14010896)
Introduced
21 February 2000
Last action
22 March 2000 · Antwort
Status
Beantwortet
Sponsors
—
Subjects
Discovery layer
Source updated
26 July 2022
Summary
Gene therapy studies in the Federal Republic of Germany, results, official controls, assessment by ethics committees, participation of private companies, expected future chances of recovery, federal funding for testing and research into somatic gene therapy
Machine translation from German. The official text remains authoritative.
Timeline
21 February 2000
Minor interpellation
Consequences for the Federal Republic of Germany from the death following gene therapy in the USA and evaluation of the German gene therapy studies (G-SIG: 14010896)
Source: BT
22 March 2000
Antwort
Consequences for the Federal Republic of Germany from the death following gene therapy in the USA and evaluation of the German gene therapy studies (G-SIG: 14010896)
Source: BT
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
2 official files
14/3038
Drucksache · DE · 22 March 2000
14/2760
Drucksache · DE · 21 February 2000
Sponsors
- Fraktion der PDS · Fraktion der PDS · initiative
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://dip.bundestag.de/vorgang/konsequenzen-fur-die-bundesrepublik-deutschland-aus-dem-todesfall-nach-einer-gen/103966
- Open data entity: https://search.dip.bundestag.de/api/v1/vorgang/103966
- germany · 103966 · source updated 26 July 2022